Novo Nordisk is developing a new obesity drug that clinical trials suggest rivals Zepbound in effectiveness, and Eli Lilly is testing a drug that could end up being even more effective than the current products on the market
Contact your physician or go to the ER if you experience: Vomiting lasting more than 24 hours, preventing you from keeping fluids down Dehydration signs such as dizziness, dry mouth, rapid heartbeat, or dark urine Sharp, constant upper abdominal pain, especially if it radiates to your back Fever, jaundice (yellowing of the skin or eyes), or bloody vomit/stool Confusion, extreme fatigue, or fainting Most individuals can manage GLP-1 side effects at home, but knowing when to seek further care is essential
Mistake 3: obsessing over the scale Daily weigh-ins can be psychologically destructive during GLP-1 therapy
Companies that successfully navigate this transition will not only capture significant market share but also establish India's leadership position in next-generation therapeutics for global health challenges